Brief: Cogent Biosciences Announces Pricing Of Concurrent Public Offerings Of Common Stock And 1.625% Convertible Senior Notes Due 2031
12/11/2025 04:17
Nov 11 (Reuters) - Cogent Biosciences Inc COGT.O: COGENT BIOSCIENCES ANNOUNCES PRICING OF CONCURRENT PUBLIC OFFERINGS OF COMMON STOCK AND 1.625% CONVERTIBLE SENIOR NOTES DUE 2031 COGENT BIOSCIENCES INC - PRICES PUBLIC OFFERING OF 9,677,420 SHARES AT $31.00 EACH Source text: ID:nGNX4Dwy8Q Further company coverage: COGT.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cogent Biosciences
See all newsBrief: Cogent Biosciences - Enters Commercial Supply Agreement With Hovione On Sept 1, 2026 - SEC Filing
Brief: Cogent Biosciences - May Offer Up To $400 Million In Common Stock Through Guggenheim Securities
Cogent Biosciences Q2 net loss widens on higher expenses
Brief: Cogent Biosciences Q2 Net Income USD -96.405 Million
U.S. STOCKS ON THE MOVE-Snowflake, Best Buy, Kohl's